124
Views
1
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Investigation of mindin levels in hypertensive patients with left ventricular hypertrophy and QRS fragmentation on electrocardiography

, , , , , , , & show all
Pages 544-549 | Received 18 Oct 2017, Accepted 11 Dec 2017, Published online: 21 Dec 2017

References

  • Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562.
  • Querejeta R, Varo N, Lopez B, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation. 2000;101:1729–1735.
  • Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91:250–256.
  • Verdecchia P, Angeli F, Borgioni C, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens. 2003;16:895–899.
  • Bian ZY, Wei X, Deng S, et al. Disruption of mindin exacerbates cardiac hypertrophy and fibrosis. J Mol Med. 2012;90:895–910.
  • Yan L, Wei X, Tang QZ, et al. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc Res. 2011;92:85–94.
  • Higashijima S, Nose A, Eguchi G, et al. Mindin/F-spondin family: novel ECM proteins expressed in the zebrafish embryonic axis. Dev Biol. 1997;192:211–227.
  • Feinstein Y, Borrell V, Garcia C, et al. F-spondin and mindin: two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons. Development. 1999;126:3637–3648.
  • Basaran Y, Tigen K, Karaahmet T, et al. Fragmented QRS complexes are associated with cardiac fibrosis and significant intraventricular systolic dyssynchrony in nonischemic dilated cardiomyopathy patients with a narrow QRS interval. Echocardiography. 2011;28:62–68.
  • Das MK, Suradi H, Maskoun W, et al. Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis. Circ Arrhythm Electrophysiol. 2008;1:258–268.
  • Park SJ, On YK, Kim JS, et al. Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of fallot. Am J Cardiol. 2012;109:110–115.
  • Homsi M, Alsayed L, Safadi B, et al. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2009;14:319–326.
  • Terho HK, Tikkanen J, Junttila J, et al. Prevalence and long-term prognosis of fragmented QRS in standard 12-lead electrocardiogram in middle-aged subjects. Am J Cardiol. 2014;114:141–147.
  • Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072.
  • Wood PW, Choy JB, Nanda NC, et al. Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography. 2014;31:87–100.
  • Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.
  • Lang RM, Bierig M, Devereux RB, American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, et al. European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.
  • Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462–1536.
  • Pietrasik G, Zaręba W. QRS fragmentation: diagnostic and prognostic significance. Cardiol J. 2012;19:114–121.
  • Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007;117:568–575.
  • Zhu LH, Wang A, Luo P, et al. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. J Hepatol. 2014;60:1046–1054.
  • Guleng B, Ya-Mei L, Lin Ren J. Mindin is upregulated during colitis and may activate NF-κB in a TLR-9 mediated manner. WJG. 2010;16:1070–1075.
  • Kahvecioglu S, Guclu M, Ustundag Y, et al. Evaluation of serum spondin 2 levels in the different stages of type 2 diabetic nephropathy. Nephrology (Carlton). 2015;20:721.
  • Murakoshi M, Tanimoto M, Gohda T, et al. Mindin: a novel marker for podocyte injury in diabetic nephropathy. Nephrol Dial Transplant. 2011;26:2153–2160.
  • Sun P, Zhang P, Wang P-X, et al. Mindin deficiency protects the liver against ischemia/reperfusion injury. J Hepatol. 2015;63:1198–1211.
  • Li Z, Garantziotis S, Jia W, et al. The extracellular matrix protein mindin regulates trafficking of murine eosinophils into the airspace. J Leukoc Biol. 2009;85:124–131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.